249 related articles for article (PubMed ID: 34732383)
1. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
[TBL] [Abstract][Full Text] [Related]
2. Impact of controlled ice nucleation and lyoprotectants on nanoparticle stability during Freeze-drying and upon storage.
Luo WC; Zhang W; Kim R; Chong H; Patel SM; Bogner RH; Lu X
Int J Pharm; 2023 Jun; 641():123084. PubMed ID: 37245738
[TBL] [Abstract][Full Text] [Related]
3. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
4. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
6. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
7. Devitrification of lyoprotectants: A critical determinant for bacteriophages inactivation in freeze-drying and storage.
Zheng H
Food Res Int; 2023 Nov; 173(Pt 1):113307. PubMed ID: 37803616
[TBL] [Abstract][Full Text] [Related]
8. Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study.
Mitrović JR; Bjelošević Žiberna M; Vukadinović A; Knutson DE; Sharmin D; Kremenović A; Ahlin Grabnar P; Planinšek O; Lunter D; Cook JM; Savić MM; Savić SD
Eur J Pharm Sci; 2023 Oct; 189():106557. PubMed ID: 37544333
[TBL] [Abstract][Full Text] [Related]
9. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
11. Tableting behavior of freeze and spray-dried excipients in pharmaceutical formulations.
Madi C; Hsein H; Busignies V; Tchoreloff P; Mazel V
Int J Pharm; 2024 May; 656():124059. PubMed ID: 38552753
[TBL] [Abstract][Full Text] [Related]
12. On the use of tert-butanol/water cosolvent systems in production and freeze-drying of poly-ε-caprolactone nanoparticles.
Zelenková T; Barresi AA; Fissore D
J Pharm Sci; 2015 Jan; 104(1):178-90. PubMed ID: 25421731
[TBL] [Abstract][Full Text] [Related]
13. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
14. Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine.
Khan MDFH; Youssef M; Nesdoly S; Kamen AA
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932234
[TBL] [Abstract][Full Text] [Related]
15. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
[TBL] [Abstract][Full Text] [Related]
17. Size control in production and freeze-drying of poly-ε-caprolactone nanoparticles.
Zelenková T; Fissore D; Marchisio DL; Barresi AA
J Pharm Sci; 2014 Jun; 103(6):1839-50. PubMed ID: 24737658
[TBL] [Abstract][Full Text] [Related]
18. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying.
Doktorovova S; Shegokar R; Fernandes L; Martins-Lopes P; Silva AM; Müller RH; Souto EB
Pharm Dev Technol; 2014 Dec; 19(8):922-9. PubMed ID: 24099511
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization.
Fonte P; Araújo F; Seabra V; Reis S; van de Weert M; Sarmento B
Int J Pharm; 2015 Dec; 496(2):850-62. PubMed ID: 26474964
[TBL] [Abstract][Full Text] [Related]
20. Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation.
Quaak SG; Haanen JB; Beijnen JH; Nuijen B
AAPS PharmSciTech; 2010 Mar; 11(1):344-50. PubMed ID: 20204715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
